# Comparison Between Low-Dose and High-Dose Nepafenac Sodium

> **NCT07749027** · NA · COMPLETED · sponsor: **Muhammad Aamir Latif** · enrollment: 176 (actual)

## Conditions studied

- Cataract

## Interventions

- **DRUG:** Nepafenac sodium (High-dose )
- **DRUG:** Nepafenac sodium (Low-dose )

## Key facts

- **NCT ID:** NCT07749027
- **Lead sponsor:** Muhammad Aamir Latif
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-01-01
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 176 (ACTUAL)
- **Last updated:** 2026-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07749027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07749027, "Comparison Between Low-Dose and High-Dose Nepafenac Sodium". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07749027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*